Ista Pharmaceuticals Inc., an Irvine-based drug maker, said Wednesday that one of its eye drug candidates met goals in a late-stage clinical trial. Ista said that Xibrom QD did significantly better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback